Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
4,450,764
-
Shares change
-
+1,175,204
-
Total reported value, excl. options
-
$7,963,000
-
Value change
-
+$2,116,276
-
Put/Call ratio
-
116%
-
Number of buys
-
14
-
Number of sells
-
-7
-
Price
-
$1.79
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2021
37 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,450,764 shares
.
Largest 10 shareholders include BlackRock Inc. (910,966 shares), Davy Global Fund Management Ltd (835,363 shares), VANGUARD GROUP INC (714,372 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (490,356 shares), Carroll Financial Associates, Inc. (320,000 shares), GEODE CAPITAL MANAGEMENT, LLC (261,671 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (248,700 shares), Vontobel Holding Ltd. (120,000 shares), DEARBORN PARTNERS LLC (96,901 shares), and SIMPLEX TRADING, LLC (86,816 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.